White matter hyperintensity burden in elderly cohort studies: The Sunnybrook Dementia Study, Alzheimer's Disease Neuroimaging Initiative, and Three‐City Study-Reference-Cited by-同舟云学术

White matter hyperintensity burden in elderly cohort studies: The Sunnybrook Dementia Study, Alzheimer's Disease Neuroimaging Initiative, and Three‐City Study

Published:2015-07-21 Issue:2 Volume:12 Page:203-210
ISSN:1552-5260
Container-title:Alzheimer's & Dementia
language:en
Short-container-title:Alzheimer's & Dementia

Author:

Ramirez Joel¹²,McNeely Alicia A.¹²,Scott Christopher J.M.¹²,Masellis Mario¹²³⁴⁵,Black Sandra E.¹²³⁵,

Affiliation:

1. LC Campbell Cognitive Neurology Research Unit, Brain Sciences Research Program Sunnybrook Research Institute Toronto Canada

2. Heart & Stroke Foundation Canadian Partnership for Stroke Recovery Sunnybrook Health Sciences Centre (SHSC) Toronto Canada

3. Institute of Medical Science University of Toronto (UT) Toronto Canada

4. Neurogenetics Section Centre for Addiction and Mental Health Toronto Canada

5. Department of Medicine Neurology, SHSC and UT Toronto Canada

Funder

Canadian Institutes of Health Research

Alzheimer Society

Sunnybrook Research Institute

Alzheimer Association

Heart and Stroke Foundation Canadian Partnership for Stroke Recovery

Campbell Foundation

Publisher

Wiley

Subject

Psychiatry and Mental health,Cellular and Molecular Neuroscience,Geriatrics and Gerontology,Neurology (clinical),Developmental Neuroscience,Health Policy,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1016/j.jalz.2015.06.1886

Reference58 articles.

1. Alzheimer's Disease International.World Alzheimer Report 2014: Dementia and risk reduction: An analysis of protective and modifiable factors.London UK:2014.

2. Incidence of dementia and major subtypes in Europe: A collaborative study of population‐based cohorts. Neurologic Diseases in the Elderly Research Group;Fratiglioni L;Neurology,2000

3. Vascular cognitive impairment: Small vessels, big toll: Introduction;Black S;Stroke,2009

4. Cerebrovascular pathology in cognitive impairment: New (in)sights;Knopman DS;Neurology,2012

5. De la TorreJC.Detection prevention and pre‐clinical treatment of Alzheimer's disease.J Alzheimers Dis2014;64–65

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oligodendrocyte Dysfunction in Tauopathy: A Less Explored Area in Tau-Mediated Neurodegeneration;Cells;2024-06-27

2. VasCog 2023: 20 years of research on vascular behavioural and cognitive disorders;Cerebral Circulation - Cognition and Behavior;2024

3. Association of plasma biomarkers with cognition, cognitive decline, and daily function across and within neurodegenerative diseases: Results from the Ontario Neurodegenerative Disease Research Initiative;Alzheimer's & Dementia;2023-12-17

4. White matter hyperintensities and smaller cortical thickness are associated with neuropsychiatric symptoms in neurodegenerative and cerebrovascular diseases;Alzheimer's Research & Therapy;2023-06-20

5. Lifelong Cognitive Reserve, Imaging Markers of Brain Aging, and Cognitive Function in Dementia-Free Rural Older Adults: A Population-Based Study;Journal of Alzheimer's Disease;2023-03-07